ArticleOncotarget2017

RASSF6 downregulation promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal cancer.

Rui Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.